UAB "Pharma medica" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 4,690,820 |
| 1,379,653 |
| 1,271,639 |
| 1,079,765 |
| 317,578 |
| 38.10 |
| 23.02 |
| 2,507,237 |
| 158,004 |
| 666,215 |
| 1,998,119 |
| 0.39 |
| 0.06 |
| - |
| - |
| 27.10 |
| 1,271,363 |
| 2023 |
|---|
| 4,406,176 |
| 1,044,118 |
| 1,199,918 |
| 1,019,818 |
| 241,663 |
| 40.25 |
| 23.15 |
| 3,436,605 |
| 432,987 |
| 693,682 |
| 3,175,872 |
| 0.62 |
| 0.13 |
| - |
| - |
| 27.23 |
| 1,199,934 |
| 2024 |
|---|
| 2,615,623 |
| 871,874 |
| 152,521 |
| 113,285 |
| 37,762 |
| 26.96 |
| 4.33 |
| 3,549,890 |
| 364,158 |
| 1,076,037 |
| 2,837,214 |
| 0.96 |
| 0.10 |
| - |
| - |
| 5.89 |
| 154,151 |
| 2024 |
|---|
| 2,615,623 |
| 871,874 |
| 152,521 |
| 113,285 |
| 37,762 |
| 26.96 |
| 4.33 |
| 3,549,890 |
| 364,158 |
| 1,076,037 |
| 2,837,214 |
| 0.96 |
| 0.10 |
| - |
| - |
| 5.89 |
| 154,151 |
Turnover (€)
2024
Turnover (€)
2,615,623 €-41 % *
Sales per employee (€)
871,874 €-17 % *
Profit before tax (€)
152,521 €-87 % *
Net Profit (€)
113,285 €-89 % *
Profit per employee (€)
37,762 €-84 % *
Total profitability (%)
26.96 %-33.02 % *
Net profitability (%)
4.33 %-81.30 % *
Equity (€)
3,549,890 €3 % *
Amounts Payable And Liabilities (€)
364,158 €-16 % *
Non-current Assets (€)
1,076,037 €55 % *
CurrentAssets (€)
2,837,214 €-11 % *
Working capital requirement
0.96 54.84 % *
Debt-to-equity ratio
0.10 -23.08 % *
EBITDA margin (%)
-EBITDA (€)
-EBIT margin (%)
5.89 %-78.37 % *
EBIT (€)
154,151 €-87 % *
